Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market Size, Share & Trends Analysis by Product (Innovative, Generic), Dosage Form (Injectable, Creams), ...

Chinese API maker Jilin Shulan Synthetic Pharma was hit with a warning letter by the FDA, which cited numerous quality-control and data-integrity issues. The letter, which was posted on the regulatory ...

Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.

The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...

Key Companies Covered are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Mylan N.V., AbbVie Inc., Sun Pharmaceutical Industries ...

The global active pharmaceutical ingredients market is on a promising growth path with the size valued at US$ 222.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of ...

BizVibe has made available 2,000+ company profiles for the resin, synthetic rubber, and artificial and synthetic fibers and filaments manufacturing industry group on its B2B platform. Companies listed ...

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...